Literature DB >> 14757828

Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns.

Sonia Terrillon1, Claude Barberis, Michel Bouvier.   

Abstract

V1a vasopressin receptor (V1aR) and V2 vasopressin receptor (V2R) present distinct mechanisms of agonist-promoted trafficking. Although both receptors are endocytosed by way of beta-arrestin-dependent processes, beta-arrestin dissociates rapidly from V1aR, allowing its rapid recycling to the plasma membrane while beta-arrestin remains associated with V2R in the endosomes, leading to their intracellular accumulation. Here, we demonstrate that, when coexpressed, the two receptors can be endocytosed as stable heterodimers. On activation with a nonselective agonist, both receptors cotrafficked with beta-arrestin in endosomes where the stable interaction inhibited the recycling of V1aR to the plasma membrane, thus conferring a V2R-like endocytotic/recycling pattern to the V1aR/V2R heterodimer. Coexpression of the constitutively internalized R137HV2R mutant with V1aR was sufficient to promote cointernalization of V1aR in beta-arrestin-positive vesicles even in the absence of agonist stimulation. This finding indicates that internalization of the heterodimer does not require activation of each of the protomers. Consistent with this notion, a V1aR-selective agonist led to the coendocytosis of V2R. In that case, however, the V1aR/V2R heterodimer was not stably associated with beta-arrestin, and both receptors were recycled back to the cell surface, indicating that the complex followed the V1aR endocytotic/recycling path. Taken together, these results suggest that heterodimerization regulates the endocytotic processing of G protein-coupled receptors and that the identity of the activated protomer within the heterodimer determines the fate of the internalized receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757828      PMCID: PMC341772          DOI: 10.1073/pnas.0305322101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.

Authors:  M Rocheville; D C Lange; U Kumar; R Sasi; R C Patel; Y C Patel
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

2.  AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration.

Authors:  S AbdAlla; H Lother; U Quitterer
Journal:  Nature       Date:  2000-09-07       Impact factor: 49.962

3.  Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors.

Authors:  R H Oakley; S A Laporte; J A Holt; M G Caron; L S Barak
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

4.  Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.

Authors:  J P Morello; A Salahpour; A Laperrière; V Bernier; M F Arthus; M Lonergan; U Petäjä-Repo; S Angers; D Morin; D G Bichet; M Bouvier
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

5.  G-protein-coupled receptors function as oligomers in vivo.

Authors:  M C Overton; K J Blumer
Journal:  Curr Biol       Date:  2000-03-23       Impact factor: 10.834

6.  Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization.

Authors:  R H Oakley; S A Laporte; J A Holt; L S Barak; M G Caron
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

7.  Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.

Authors:  P H Anborgh; J L Seachrist; L B Dale; S S Ferguson
Journal:  Mol Endocrinol       Date:  2000-12

8.  Historadioautographic localization, pharmacology and ontogeny of V(1a) vasopressin binding sites in the rat kidney.

Authors:  M P Arpin-Bott; E Waltisperger; M J Freund-Mercier; M E Stoeckel
Journal:  Nephron       Date:  1999-09       Impact factor: 2.847

9.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation.

Authors:  B A Jordan; N Trapaidze; I Gomes; R Nivarthi; L A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

10.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).

Authors:  S Angers; A Salahpour; E Joly; S Hilairet; D Chelsky; M Dennis; M Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  57 in total

1.  Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

2.  Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

3.  V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH.

Authors:  Brigitte Murat; Dominic Devost; Miriam Andrés; Julie Mion; Véra Boulay; Maithé Corbani; Hans H Zingg; Gilles Guillon
Journal:  Mol Endocrinol       Date:  2012-02-02

4.  Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.

Authors:  Maithé Corbani; Miguel Trueba; Stoytcho Stoev; Brigitte Murat; Julie Mion; Véra Boulay; Gilles Guillon; Maurice Manning
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

Review 5.  GPCRs and Signal Transducers: Interaction Stoichiometry.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2018-05-05       Impact factor: 14.819

6.  Dimerization of the thyrotropin-releasing hormone receptor potentiates hormone-dependent receptor phosphorylation.

Authors:  Gyun Jee Song; Brian W Jones; Patricia M Hinkle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

Review 7.  The A(2A)-adenosine receptor: a GPCR with unique features?

Authors:  J Zezula; M Freissmuth
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

8.  Heterodimerization with Its splice variant blocks the ghrelin receptor 1a in a non-signaling conformation: a study with a purified heterodimer assembled into lipid discs.

Authors:  Sophie Mary; Jean-Alain Fehrentz; Marjorie Damian; Gérald Gaibelet; Hélène Orcel; Pascal Verdié; Bernard Mouillac; Jean Martinez; Jacky Marie; Jean-Louis Banères
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

9.  Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.

Authors:  Melissa A Byers; Psachal A Calloway; Laurie Shannon; Heather D Cunningham; Sarah Smith; Fang Li; Brian C Fassold; Charlotte M Vines
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

10.  Monitoring the state of cholecystokinin receptor oligomerization after ligand binding using decay of time-resolved fluorescence anisotropy.

Authors:  Kaleeckal G Harikumar; Laurence J Miller
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.